Zoetis
ZTS
$158.42
Share price
3.30%
Change (1 day)
-8.93%
Change (1 year)
Categories
Zoetis (ZTS) - P/B ratio
P/B ratio as of April 2024 : 14.5
According to Zoetis's latest financial reports the company has a price-to-book ratio of 14.5.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Zoetis - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 18.2 | 17.04% |
| 2022-12-31 | 15.5 | -38.95% |
| 2021-12-31 | 25.4 | 21.88% |
| 2020-12-31 | 20.8 | -10.3% |
| 2019-12-31 | 23.2 | 23.79% |
| 2018-12-31 | 18.8 | -4.48% |
| 2017-12-31 | 19.7 | 11.46% |
| 2016-12-31 | 17.6 | -19.28% |
| 2015-12-31 | 21.8 | 35.41% |
| 2014-12-31 | 16.1 | -5.04% |
| 2013-12-31 | 17.0 | |
| 2012-12-31 | N/A | |
| 2011-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.61 | -88.90% | 🇺🇸 USA |
 Eli Lilly LLY | 64.1 | 342.00% | 🇺🇸 USA |
 Sanofi SNY | 1.49 | -89.70% | 🇫🇷 France |
 Merck MRK | 8.83 | -39.13% | 🇺🇸 USA |
 Phibro Animal Health
PAHC | 1.90 | -86.88% | 🇺🇸 USA |
 Heska Corporation
HSKA | 3.14 | -78.38% | 🇺🇸 USA |